These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 272137)

  • 1. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.
    Cohen DJ; Shaywitz BA; Caparulo B; Young JG; Bowers MB
    Arch Gen Psychiatry; 1978 Feb; 35(2):245-50. PubMed ID: 272137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 8. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 10. Gilles de la Tourette's syndrome in twins: clinical and neurochemical data.
    Goetz CG; Tanner CM
    Mov Disord; 1990; 5(2):173-5. PubMed ID: 1691443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report.
    Shaywitz BA; Cohen DJ; Bowers MB
    J Pediatr; 1977 Jan; 90(1):67-71. PubMed ID: 830896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma.
    Emanuelsson BM; Widerlöv E; Walléus H; Paalzow LK
    Psychopharmacology (Berl); 1987; 92(2):144-9. PubMed ID: 2440072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 18. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in the CSF of conscious unrestrained cats.
    Degrell I; Zenner K; Kummer P; Stock G
    Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.